206 related articles for article (PubMed ID: 31920303)
1. A Novel Liposomal S-Propargyl-Cysteine: A Sustained Release of Hydrogen Sulfide Reducing Myocardial Fibrosis via TGF-β1/Smad Pathway.
Tran BH; Yu Y; Chang L; Tan B; Jia W; Xiong Y; Dai T; Zhong R; Zhang W; Le VM; Rose P; Wang Z; Mao Y; Zhu YZ
Int J Nanomedicine; 2019; 14():10061-10077. PubMed ID: 31920303
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective effects and pharmacokinetic properties of a controlled release formulation of a novel hydrogen sulfide donor in rats with acute myocardial infarction.
Tran BH; Huang C; Zhang Q; Liu X; Lin S; Liu H; Wang S; Zhu YZ
Biosci Rep; 2015 Apr; 35(3):. PubMed ID: 26182378
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effects of a novel hydrogen sulfide agent-controlled release formulation of S-propargyl-cysteine on heart failure rats and molecular mechanisms.
Huang C; Kan J; Liu X; Ma F; Tran BH; Zou Y; Wang S; Zhu YZ
PLoS One; 2013; 8(7):e69205. PubMed ID: 23874913
[TBL] [Abstract][Full Text] [Related]
4. Novel H
Wu D; Hu Q; Xiong Y; Zhu D; Mao Y; Zhu YZ
Redox Biol; 2018 May; 15():243-252. PubMed ID: 29288927
[TBL] [Abstract][Full Text] [Related]
5. A novel dendritic mesoporous silica based sustained hydrogen sulfide donor for the alleviation of adjuvant-induced inflammation in rats.
Yu Y; Wang Z; Yang Q; Ding Q; Wang R; Li Z; Fang Y; Liao J; Qi W; Chen K; Li M; Zhu YZ
Drug Deliv; 2021 Dec; 28(1):1031-1042. PubMed ID: 34060389
[TBL] [Abstract][Full Text] [Related]
6. Novel hydrogen sulfide-releasing compound, S-propargyl-cysteine, prevents STZ-induced diabetic nephropathy.
Qian X; Li X; Ma F; Luo S; Ge R; Zhu Y
Biochem Biophys Res Commun; 2016 May; 473(4):931-938. PubMed ID: 27055593
[TBL] [Abstract][Full Text] [Related]
7. S-propargyl-cysteine attenuates inflammatory response in rheumatoid arthritis by modulating the Nrf2-ARE signaling pathway.
Wu WJ; Jia WW; Liu XH; Pan LL; Zhang QY; Yang D; Shen XY; Liu L; Zhu YZ
Redox Biol; 2016 Dec; 10():157-167. PubMed ID: 27744121
[TBL] [Abstract][Full Text] [Related]
8. The protective effects of endogenous hydrogen sulfide modulator, S-propargyl-cysteine, on high glucose-induced apoptosis in cardiomyocytes: A novel mechanism mediated by the activation of Nrf2.
Yang H; Mao Y; Tan B; Luo S; Zhu Y
Eur J Pharmacol; 2015 Aug; 761():135-43. PubMed ID: 25979858
[TBL] [Abstract][Full Text] [Related]
9. S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway.
Wang Q; Liu HR; Mu Q; Rose P; Zhu YZ
J Cardiovasc Pharmacol; 2009 Aug; 54(2):139-46. PubMed ID: 19546814
[TBL] [Abstract][Full Text] [Related]
10. The Pharmacological Effects of S-Propargyl-Cysteine, a Novel Endogenous H2S-Producing Compound.
Wen YD; Zhu YZ
Handb Exp Pharmacol; 2015; 230():325-36. PubMed ID: 26162842
[TBL] [Abstract][Full Text] [Related]
11. Effects of hydrogen sulfide on myocardial fibrosis and PI3K/AKT1-regulated autophagy in diabetic rats.
Xiao T; Luo J; Wu Z; Li F; Zeng O; Yang J
Mol Med Rep; 2016 Feb; 13(2):1765-73. PubMed ID: 26676365
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen sulfide alleviates myocardial collagen remodeling in association with inhibition of TGF-β/Smad signaling pathway in spontaneously hypertensive rats.
Sun L; Jin H; Sun L; Chen S; Huang Y; Liu J; Li Z; Zhao M; Sun Y; Tang C; Zhao B; Du J
Mol Med; 2015 Jan; 20(1):503-15. PubMed ID: 25222913
[TBL] [Abstract][Full Text] [Related]
13. Novel Angiogenic Activity and Molecular Mechanisms of ZYZ-803, a Slow-Releasing Hydrogen Sulfide-Nitric Oxide Hybrid Molecule.
Hu Q; Wu D; Ma F; Yang S; Tan B; Xin H; Gu X; Chen X; Chen S; Mao Y; Zhu YZ
Antioxid Redox Signal; 2016 Sep; 25(8):498-514. PubMed ID: 27174595
[TBL] [Abstract][Full Text] [Related]
14. Preclinical assessment of the distribution, metabolism, and excretion of S-propargyl-cysteine, a novel H2S donor, in Sprague-Dawley rats.
Zheng YT; Zhu JH; Ma G; Zhu Q; Yang P; Tan B; Zhang JL; Shen HX; Xu JL; Zhu YZ; Cai WM
Acta Pharmacol Sin; 2012 Jun; 33(6):839-44. PubMed ID: 22543704
[TBL] [Abstract][Full Text] [Related]
15. H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S?
Ma K; Liu Y; Zhu Q; Liu CH; Duan JL; Tan BK; Zhu YZ
PLoS One; 2011; 6(6):e20525. PubMed ID: 21738579
[TBL] [Abstract][Full Text] [Related]
16. [Garlicin ameliorated pressure overload induced myocardial fibrosis in rats through partial inhibiting TGF-beta1 mediated Smads signal].
Zhang HX; Shi ZX; Jia HZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 May; 32(5):666-70. PubMed ID: 22679731
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway.
Zhang Y; Shao L; Ma A; Guan G; Wang J; Wang Y; Tian G
Hypertens Res; 2014 Jan; 37(1):43-9. PubMed ID: 24089264
[TBL] [Abstract][Full Text] [Related]
18. Silymarin ameliorates diabetic cardiomyopathy via inhibiting TGF-β1/Smad signaling.
Meng S; Yang F; Wang Y; Qin Y; Xian H; Che H; Wang L
Cell Biol Int; 2019 Jan; 43(1):65-72. PubMed ID: 30489003
[TBL] [Abstract][Full Text] [Related]
19. Vasorelaxant Effect of a New Hydrogen Sulfide-Nitric Oxide Conjugated Donor in Isolated Rat Aortic Rings through cGMP Pathway.
Wu D; Hu Q; Ma F; Zhu YZ
Oxid Med Cell Longev; 2016; 2016():7075682. PubMed ID: 26635911
[TBL] [Abstract][Full Text] [Related]
20. The novel H
Testai L; Marino A; Piano I; Brancaleone V; Tomita K; Di Cesare Mannelli L; Martelli A; Citi V; Breschi MC; Levi R; Gargini C; Bucci M; Cirino G; Ghelardini C; Calderone V
Pharmacol Res; 2016 Nov; 113(Pt A):290-299. PubMed ID: 27616550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
